Medizinische Universität Graz - Research portal
Department of Internal Medicine
Division of Oncology
SCI/PUBMED listed | all typs of publications | all by year and first author | MUG authors |
** = Publications listed in SCI/SSCI/Pubmed
Journal Articles
** Ay, C; Grilz, E; Nopp, S; Moik, F; Königsbrügge, O; Klimek, P; Thurner, S; Posch, F; Pabinger, I
Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study.
Res Pract Thromb Haemost. 2023; 7(1): 100026
Doi: 10.1016/j.rpth.2022.100026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Balic, M; Thomssen, C; Gnant, M; Harbeck, N
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer - A Brief Summary of the Consensus Discussion.
Breast Care (Basel). 2023; 18(3):213-222
Doi: 10.1159/000530584
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12):
Doi: 10.1136/jitc-2023-007765
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Pichler, M
Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00899-w
Web of Science
FullText
FullText_MUG
** Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Sölkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer. 2023; 180:108-116
Doi: 10.1016/j.ejca.2022.12.003
Web of Science
PubMed
FullText
FullText_MUG
** Bögemann, M; Facchini, G; Bauernhofer, T; Cathomas, R; Xylinas, E; Tombal, B
Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice.
Ir J Med Sci. 2023;
Doi: 10.1007/s11845-023-03303-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1):
Doi: 10.3390/ijms24010818
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchacher, L; Richtig, G; Dernoscheg, M; Richtig, E; Koch, L
Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
J Eur Acad Dermatol Venereol. 2023; 37(5):e605-e607
Doi: 10.1111/jdv.18871
Web of Science
PubMed
FullText
FullText_MUG
** Buschhorn, L; Odoni, DI; Geuder, J; Odinius, TO; Wagner, CV; Jilg, S; Hoeckendorf, U; Wahida, A; Schlesner, M; Reiter, A; Jawhar, M; Jost, PJ
Transcriptomic profiling does dot refine mastocytosis diagnosis
HAEMATOLOGICA. 2023; 108(11): 3125-3130.
Doi: 10.3324/haematol.2022.282617
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dąbrowska, A; Grubba, M; Balihodzic, A; Szot, O; Sobocki, BK; Perdyan, A
The Role of Regulatory T Cells in Cancer Treatment Resistance.
Int J Mol Sci. 2023; 24(18):
Doi: 10.3390/ijms241814114
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dill, V; Wagner, CV; Keller, EC; Fernandez-Hernandez, FJ; Shoumariyeh, K; Odinius, TO; Buschhorn, L; Hauch, RT; Suren, C; Hecker, JS; Herhaus, P; Sandherr, M; Schmidt, B; Slotta-Huspenina, J; Bassermann, F; Höckendorf, U; Jilg, S; Branca, C; Vosberg, S; Jost, PJ
Elevated RIPK3 correlates with disease burden in myelofibrosis.
Blood Adv. 2023; 7(7):1219-1224
Doi: 10.1182/bloodadvances.2021006838
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Doleschal, B; Taghizadeh, H; Lentner, T; Riedl, JM; Granitzer, J; Morariu, D; Decker, J; Aichberger, KJ; Webersinke, G; Kirchweger, P; Petzer, A; Rumpold, H
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
ESMO Open. 2023; 8(6):102064
Doi: 10.1016/j.esmoop.2023.102064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Egger, V; Hutterer, GC; Mischinger, J; Seles, M; Pichler, R; Mannweiler, S; Huber, K; Balihodzic, A; Spiegelberg, J; Bauernhofer, T; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
World J Urol. 2023; 41(5):1359-1364
Doi: 10.1007/s00345-023-04379-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Eredics, K; Wehrberger, C; Edlinger, L; Müller, U; Rauchenwald, M; Wehrberger, M; Madersbacher, S
Urinary Incontinence, Quality of Life, and Risk Factors in a Geriatric Cohort.
Urol Int. 2023; 1-6.
Doi: 10.1159/000531582
Web of Science
PubMed
FullText
FullText_MUG
** Fankhauser, CD; Jandari, A; Collette, L; Tandstad, T; Jiang, DM; De, Giorgi, U; Sweeney, C; Terbuch, A; Chovanec, M; Huddart, R; Bokemeyer, C; Beyer, J; Gillessen, S
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma.
Eur Urol Open Sci. 2023; 56:25-28
Doi: 10.1016/j.euros.2023.08.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fischer, S; Rothermundt, C; Stalder, O; Terbuch, A; Hermanns, T; Zihler, D; Müller, B; Fankhauser, CD; Hirschi-Blickenstorfer, A; Seifert, B; Kluth, LA; Ufe, MP; Mingrone, W; Templeton, AJ; Fischer, N; Rothschild, S; Woelky, R; Gillessen, S; Cathomas, R
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Eur Urol Open Sci. 2023; 50: 57-60.
Doi: 10.1016/j.euros.2023.01.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gerger, A
Colorectal cancer special, part 2
MEMO-MAG EUR MED ONC. 2023; 16(2): 93-93.
Doi: 10.1007/s12254-023-00890-5
Web of Science
FullText
FullText_MUG
** Gerger, A
Colorectal cancer special, part 1
MEMO-MAG EUR MED ONC. 2023; 16(1): 2-2.
Doi: 10.1007/s12254-022-00866-x
Web of Science
FullText
FullText_MUG
** Gnant, M; Singer, CF; Rinnerthaler, G; Pfeiler, G; Egle, D; Balic, M; Bartsch, R
Position paper on CDK4/6 inhibitors in early breast cancer
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00878-1
Web of Science
FullText
FullText_MUG
** Gold, D; Nicolay, L; Avian, A; Greimel, E; Balic, M; Pristauz-Telsnigg, G; Tamussino, K; Trutnovsky, G
Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Maturitas. 2023; 167: 1-7.
Doi: 10.1016/j.maturitas.2022.08.013
Web of Science
PubMed
FullText
FullText_MUG
** Grossschaedl, K; Vallant, C; Dernoscheg, MT; Richtig, M; Öllinger, A; Balakirski, G; Wilsmann-Theis, D; Nguyen, VA; Weinlich, G; Tsiogka, A; Koelblinger, P; Scheffel, J; Richtig, E; Richtig, G
Usage and benefit of the Internet as a source of information on disease and therapy in dermatology.
J Dtsch Dermatol Ges. 2023; 21(11): 1383-1386.
Doi: 10.1111/ddg.15199
Web of Science
PubMed
FullText
FullText_MUG
** Grossschaedl, K; Vallant, C; Dernoscheg, MT; Richtig, M; Öllinger, A; Balakirski, G; Wilsmann-Theis, D; Nguyen, VA; Weinlich, G; Tsiogka, A; Koelblinger, P; Scheffel, J; Richtig, E; Richtig, G
[Verwendung und Nutzen des Internets als Informationsquelle für Erkrankungen und Therapien in der Dermatologie: Usage and benefit of the Internet as a source of information on disease and therapy in dermatology].
J Dtsch Dermatol Ges. 2023; 21(11): 1383-1386.
Doi: 10.1111/ddg.15199_g
PubMed
FullText
FullText_MUG
** Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Zahn, MO; Wuerstlein, R; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Mueller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinköthe, T; Resch, A; Valenti, R; Lüftner, D
Neratinib as extended adjuvant treatment of HER2-positive/HR-positive early breast cancer patients in Germany, Austria and Switzerland: interim results of the prospective, observational ELEANOR study
BREAST CARE. 2023;
Doi: 10.1159/000533657
Web of Science
FullText
FullText_MUG
** Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch, D; Pichler, M
Symptom clusters associated with complementary and alternative medicine use by cancer patients: A cross-sectional study.
PLoS One. 2023; 18(12): e0294641
Doi: 10.1371/journal.pone.0294641
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jonas, K; Prinz, F; Ferracin, M; Krajina, K; Pasculli, B; Deutsch, A; Madl, T; Rinner, B; Slaby, O; Klec, C; Pichler, M
MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib
BREAST CANCER RES. 2023; 25(1): 119
Doi: 10.1186/s13058-023-01716-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Juracek, J; Madrzyk, M; Trachtova, K; Ruckova, M; Bohosova, J; Barth, DA; Pichler, M; Stanik, M; Slaby, ONDREJ
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
CANCER GENOM PROTEOM. 2023; 20(3): 308-316.
Doi: 10.21873/cgp.20383
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54
Doi: 10.1186/s12967-022-03843-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klocker, EV
(Neo)adjuvant approaches: pavement on the road to cure-breast cancer
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00942-w
Web of Science
FullText
FullText_MUG
** Koschmieder, S; Isfort, S; Wolf, D; Heidel, FH; Hochhaus, A; Schafhausen, P; Griesshammer, M; Wolleschak, D; Platzbecker, U; Dohner, K; Jost, PJ; Parmentier, S; Schaich, M; von Bubnoff, N; Stegelmann, F; Maurer, A; Crysandt, M; Gezer, D; Kortmann, M; Franklin, J; Frank, J; Hellmich, M; Brummendorf, TH
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
ANN HEMATOL. 2023;
Doi: 10.1007/s00277-022-05080-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kraemmer, D; Königsbrügge, O; Moik, F; Wildner, B; Ay, C; Pabinger, I
Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis.
J Thromb Haemost. 2023; 21(12): 3432-3449.
Doi: 10.1016/j.jtha.2023.08.031
Web of Science
PubMed
FullText
FullText_MUG
** Lauritsen, J; Sauvé, N; Tryakin, A; Jiang, DM; Huddart, R; Heng, DYC; Terbuch, A; Winquist, E; Chovanec, M; Hentrich, M; Fankhauser, CD; Shamash, J; Del, Muro, XG; Vaughn, D; Heidenreich, A; Sternberg, CN; Sweeney, C; Necchi, A; Bokemeyer, C; Bandak, M; Jandari, A; Collette, L; Gillessen, S; Beyer, J; Daugaard, G
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Br J Cancer. 2023; 129(11):1759-1765
Doi: 10.1038/s41416-023-02443-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Mykoliuk, I; Taucher, E; Pichler, M; Smolle, J; Smolle-Juettner, FM
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
Cells. 2023; 12(3):
Doi: 10.3390/cells12030480
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lindner, AK; Lackner, F; Tymoszuk, P; Barth, DA; Seeber, A; Kocher, F; Toth, B; Hochleitner, M; Pichler, M; Pichler, R
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
BIOL SEX DIFFER. 2023; 14(1): 38
Doi: 10.1186/s13293-023-00522-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lindner, AK; Pichler, M; Maier, S; Ulmer, H; Gorreri, T; Luger, AK; Barth, DA; Seeber, A; Kocher, F; Pichler, R
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort study.
Front Oncol. 2023; 13: 1143030
Doi: 10.3389/fonc.2023.1143030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lipp, RW
Theranostics in prostate cancer
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-022-00857-y
Web of Science
FullText
FullText_MUG
** Majewski, M; Paffenholz, P; Ruf, C; Che, Y; Seidel, C; Heinzelbecker, J; Schmelz, HU; Matthies, C; Albers, P; Bokemeyer, C; Heidenreich, A; Pichler, M; Nestler, T
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
CANCER MED-US. 2023;
Doi: 10.1002/cam4.6304
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mauracher, LM; Hell, L; Moik, F; Krall, M; Englisch, C; Roiß, J; Grilz, E; Hofbauer, TM; Brostjan, C; Knapp, S; Ay, C; Pabinger, I
Neutrophils in lung cancer patients: Activation potential and neutrophil extracellular trap formation.
Res Pract Thromb Haemost. 2023; 7(2):100126
Doi: 10.1016/j.rpth.2023.100126
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mayr, C; Kiesslich, T; Bekric, D; Beyreis, M; Kittl, M; Ablinger, C; Neureiter, E; Pichler, M; Prinz, F; Ritter, M; Neureiter, D; Jakab, M; Dobias, H
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
PLOS ONE. 2023; 18(6):
Doi: 10.1371/journal.pone.0287769
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moujalled, DM; Brown, FC; Chua, CC; Dengler, MA; Pomilio, G; Anstee, NS; Litalien, V; Thompson, E; Morley, T; MacRaild, S; Tiong, IS; Morris, R; Dun, K; Zordan, A; Shah, J; Banquet, S; Halilovic, E; Morris, E; Herold, MJ; Lessene, G; Adams, JM; Huang, DCS; Roberts, AW; Blombery, P; Wei, AH
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood. 2023; 141(6):634-644
Doi: 10.1182/blood.2022016090
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Neuwirt, E; Magnani, G; Cikovic, T; Wohrle, S; Fischer, L; Kostina, A; Flemming, S; Fischenich, NJ; Saller, BS; Gorka, O; Renner, S; Agarinis, C; Parker, CN; Boettcher, A; Farady, CJ; Kesselring, R; Berlin, C; Backofen, R; Rodriguez-Franco, M; Kreutz, C; Prinz, M; Tholen, M; Reinheckel, T; Ott, T; Gross, CJ; Jost, PJ; Gross, O
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis
SCI SIGNAL. 2023; 16(768): eabh1083
Doi: 10.1126/scisignal.abh1083
Web of Science
PubMed
FullText
FullText_MUG
** Nopp, S; Moik, F; Kraler, S; Englisch, C; Preusser, M; von, Eckardstein, A; Pabinger, I; Lüscher, TF; Ay, C
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study.
J Thromb Haemost. 2023; 21(9):2461-2472
Doi: 10.1016/j.jtha.2023.04.043
Web of Science
PubMed
FullText
FullText_MUG
** Odler, B; Huemer, M; Schwaiger, E; Borenich, A; Kurnikowski, A; Krall, M; Hafner-Giessauf, H; Eleftheriadis, G; Bachmann, F; Faura, A; José, Pérez-Sáez, M; Pascual, J; Budde, K; Rosenkranz, AR; Hecking, M; Eller, K
Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients-An Analysis of Data From a Randomized Controlled Trial.
Transpl Int. 2023; 36: 11370
Doi: 10.3389/ti.2023.11370
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Perdyan, A; Sobocki, BK; Balihodzic, A; Dąbrowska, A; Kacperczyk, J; Rutkowski, J
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge-A Systematic Review.
CANCERS. 2023; 15(13): 3490
Doi: 10.3390/cancers15133490
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pfeiler, G; Hlauschek, D; Mayer, EL; Deutschmann, C; Kacerovsky-Strobl, S; Martin, M; Meisel, JL; Zdenkowski, N; Loibl, S; Balic, M; Park, H; Prat, A; Isaacs, C; Bajetta, E; Balko, JM; Bellet-Ezquerra, M; Bliss, J; Burstein, H; Cardoso, F; Fohler, H; Foukakis, T; Gelmon, KA; Goetz, M; Haddad, TC; Iwata, H; Jassem, J; Lee, SC; Linderholm, B; Los, M; Mamounas, EP; Miller, KD; Morris, PG; Munzone, E; Gal-Yam, EN; Ring, A; Shepherd, L; Singer, C; Thomssen, C; Tseng, LM; Valagussa, P; Winer, EP; Wolff, AC; Zoppoli, G; Machacek-Link, J; Schurmans, C; Huang, X; Gauthier, E; Fesl, C; Dueck, AC; DeMichele, A; Gnant, M, , PALLAS, Groups, and, Investigators
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol. 2023; JCO2300126
Doi: 10.1200/JCO.23.00126
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, R; Siska, PJ; Tymoszuk, P; Martowicz, A; Untergasser, G; Mayr, R; Weber, F; Seeber, A; Kocher, F; Barth, DA; Pichler, M; Thurnher, M
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Front Immunol. 2023; 14: 1095195
Doi: 10.3389/fimmu.2023.1095195
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Porta, C; Bamias, A; Zakopoulou, R; Myint, ZW; Cavasin, N; Iacovelli, R; Pichler, M; Kopecky, J; Kucharz, J; Rizzo, M; Galli, L; Buttner, T; De Giorgi, U; Kanesvaran, R; Fiala, O; Grande, E; Zucali, PA; Kopp, RM; Fornarini, G; Bourlon, MT; Scagliarini, S; Molina-cerrillo, J; Aurilio, G; Matrana, MR; Pichler, R; Cattrini, C; Buchler, T; Massari, F; Mollica, V; Seront, E; Calabro, F; Pinto, A; Berardi, R; Zgura, A; Mammone, G; Ansari, J; Atzori, F; Chiari, R; Caffo, O; Procopio, G; Sunela, K; Bassanelli, M; Ortega, C; Grillone, F; Landmesser, J; Merler, S; Messina, C; Kueronya, Z; Mosca, A; Bhuva, D; Santini, D; Vau, N; Morelli, F; Incorvaia, L; Rebuzzi, SE; Roviello, G; Soares, A; Zabalza, IO; Rizzo, A; Bisonni, R; Pierantoni, F; Sorgentoni, G; Monteiro, FS; Battelli, N; Buti, S; Santoni, M
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations
MINERVA UROL NEPHROL. 2023; 75(4): 460-470.
Doi: 10.23736/S2724-6051.23.05369-7
Web of Science
PubMed
FullText
FullText_MUG
** Pototschnig, I; Feiler, U; Diwoky, C; Vesely, PW; Rauchenwald, T; Paar, M; Bakiri, L; Pajed, L; Hofer, P; Kashofer, K; Sukhbaatar, N; Schoiswohl, G; Weichhart, T; Hoefler, G; Bock, C; Pichler, M; Wagner, EF; Zechner, R; Schweiger, M
Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
J Cachexia Sarcopenia Muscle. 2023; 14(1):93-107
Doi: 10.1002/jcsm.13109
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rassner, M; Waldeck, S; Follo, M; Jilg, S; Philipp, U; Jolic, M; Wehrle, J; Jost, PJ; Peschel, C; Illert, AL; Duyster, J; Scherer, F; von, Bubnoff, N
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Int J Mol Sci. 2023; 24(6):
Doi: 10.3390/ijms24065411
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Richtig, G; Berger, M; Koeller, M; Richtig, M; Richtig, E; Scheffel, J; Maurer, M; Siebenhaar, F
Predatory journals: Perception, impact and use of Beall's list by the scientific community-A bibliometric big data study.
PLoS One. 2023; 18(7): e0287547
Doi: 10.1371/journal.pone.0287547
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Richtig, G; Kienzl, M; Rittchen, S; Roula, D; Eberle, J; Sarif, Z; Pichler, M; Hoefler, G; Heinemann, A
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro.
BIOLOGY-BASEL. 2023; 12(5):
Doi: 10.3390/biology12050706
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Robinson, I; Hochmair, MJ; Schmidinger, M; Absenger, G; Pichler, M; Nguyen, VA; Richtig, E; Rainer, BM; Ay, L; Jansen, C; Pacífico, C; Knabl, A; Sladek, B; Gasche, N; Valipour, A
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types.
Cancers (Basel). 2023; 15(13):
Doi: 10.3390/cancers15133268
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rothermundt, C; Andreou, D; Blay, JY; Brodowicz, T; Desar, IME; Dileo, P; Gelderblom, H; Haas, R; Jakob, J; Jones, RL; Judson, I; Kunz, WG; Liegl-Atzwanger, B; Lindner, LH; Messiou, C; Miah, AB; Reichardt, P; Szkandera, J; van, der, Graaf, WTA; van, Houdt, WJ; Wardelmann, E; Hofer, S, , Writing, committee, on, behalf, of, CSSS, panellists
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.
Eur J Cancer. 2023; 180: 158-179.
Doi: 10.1016/j.ejca.2022.11.008
Web of Science
PubMed
FullText
FullText_MUG
** Ruggieri, F; Jonas, K; Ferracin, M; Dengler, M; Jӓger, V; Pichler, M
MicroRNAs as regulators of tumor metabolism.
Endocr Relat Cancer. 2023; 30(8):
Doi: 10.1530/ERC-22-0267
Web of Science
PubMed
FullText
FullText_MUG
** Sallinger, K; Gruber, M; Müller, CT; Bonstingl, L; Pritz, E; Pankratz, K; Gerger, A; Smolle, MA; Aigelsreiter, A; Surova, O; Svedlund, J; Nilsson, M; Kroneis, T; El-Heliebi, A
Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
J Transl Med. 2023; 21(1): 528
Doi: 10.1186/s12967-023-04384-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Santoni, M; Massari, F; Myint, ZW; Iacovelli, R; Pichler, M; Basso, U; Kopecky, J; Kucharz, J; Buti, S; Rizzo, M; Galli, L; Buettner, T; De Giorgi, U; Kanesvaran, R; Fiala, O; Grande, E; Zucali, PA; Fornarini, G; Bourlon, MT; Scagliarini, S; Molina-Cerrillo, J; Aurilio, G; Matrana, MR; Pichler, R; Cattrini, C; Buechler, T; Seront, E; Calabro, F; Pinto, A; Berardi, R; Zgura, A; Mammone, G; Ansari, J; Atzori, F; Chiari, R; Bamias, A; Caffo, O; Procopio, G; Bassanelli, M; Merler, S; Messina, C; Kueronya, Z; Mosca, A; Bhuva, D; Vau, N; Incorvaia, L; Rebuzzi, SE; Roviello, G; Zabalza, IO; Rizzo, A; Mollica, V; Sorgentoni, G; Monteiro, FSM; Montironi, R; Battelli, N; Porta, C
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
TARGET ONCOL. 2023;
Doi: 10.1007/s11523-023-00978-2
Web of Science
PubMed
FullText
FullText_MUG
** Santoni, M; Massari, F; Myint, ZW; Iacovelli, R; Pichler, M; Basso, U; Kopecky, J; Kucharz, J; Buti, S; Salfi, A; Buettner, T; De Giorgi, U; Kanesvaran, R; Fiala, O; Grande, E; Zucali, PA; Fornarini, G; Bourlon, MT; Scagliarini, S; Molina-Cerrillo, J; Aurilio, G; Matrana, MR; Pichler, R; Cattrini, C; Buechler, T; Seront, E; Calabro, F; Pinto, A; Berardi, R; Zgura, A; Mammone, G; Ansari, J; Atzori, F; Chiari, R; Zakopoulou, R; Caffo, O; Procopio, G; Bassanelli, M; Zampiva, I; Messina, C; Kueronya, Z; Mosca, A; Bhuva, D; Vau, N; Incorvaia, L; Rebuzzi, SE; Roviello, G; Zabalza, IO; Rizzo, A; Mollica, V; Catalini, I; Monteiro, FSM; Montironi, R; Battelli, N; Rizzo, M; Porta, C
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
CLIN GENITOURIN CANC. 2023; 21(5): E309-+.
Doi: 10.1016/j.clgc.2023.03.006
Web of Science
PubMed
FullText
FullText_MUG
** Scheipner, L; Barletta, F; Cano, Garcia, C; Incesu, RB; Morra, S; Baudo, A; Assad, A; Tian, Z; Saad, F; Shariat, SF; Briganti, A; Chun, FKH; Tilki, D; Longo, N; Carmignani, L; Pichler, M; Ahyai, S; Karakiewicz, PI
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Ann Surg Oncol. 2023; 30(13):8780-8785
Doi: 10.1245/s10434-023-14367-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Scheipner, L; Tappero, S; Piccinelli, ML; Barletta, F; Garcia, CC; Incesu, RB; Morra, S; Baudo, A; Tian, Z; Saad, F; Shariat, SF; Terrone, C; De, Cobelli, O; Briganti, A; Chun, FKH; Tilki, D; Longo, N; Carmignani, L; Pichler, M; Hutterer, G; Ahyai, S; Karakiewicz, PI
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA.
World J Urol. 2023; 41(11): 2991-3000.
Doi: 10.1007/s00345-023-04589-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schranz, A; Sternad, C; Aziz, F; Wagner, D; Kornprat, P; Sucher, R; Jost, PJ; Wölfler, A; Pieber, TR; Sourij, H; Riedl, JM; Aberer, F
Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases-A Retrospective Analysis.
J Clin Med. 2023; 12(24):
Doi: 10.3390/jcm12247532
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Andreou, D; Wölfel, J; Acem, I; Aj, Van, De, Sande, M; Jeys, L; Bonenkamp, H; Pollock, R; Tunn, PU; Haas, R; Posch, F; Van, Ginkel, RJ; Verhoef, C; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, PJ; Leithner, A; Szkandera, J
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models.
Radiother Oncol. 2023; 189:109944
Doi: 10.1016/j.radonc.2023.109944
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Helmberg, W; Matzhold, EM; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Cancer Med. 2023; 12(2):1237-1246
Doi: 10.1002/cam4.4989
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Kogler, A; Andreou, D; Scheipl, S; Bergovec, M; Castellani, C; Till, H; Benesch, M; Posch, F; Szkandera, J; Smolle-Jüttner, FM; Leithner, A
Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.
Cancers (Basel). 2023; 15(6): 1733
Doi: 10.3390/cancers15061733
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Balic, M
Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023;
Doi: 10.1159/000528756
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Taghizadeh, H; Djanani, A; Eisterer, W; Gerger, A; Gruenberger, B; Gruenberger, T; Rumpold, H; Weiss, L; Winder, T; Wöll, E; Prager, GW
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement.
Front Oncol. 2023; 13:1225154
Doi: 10.3389/fonc.2023.1225154
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31
Doi: 10.1016/j.clgc.2022.10.005
Web of Science
PubMed
FullText
FullText_MUG
** Torzsok, P; Van Goubergen, J; Pichler, M; Pichler, R; Santer, FR
Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer
NUTRIENTS. 2023; 15(10): 2384
Doi: 10.3390/nu15102384
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tretter, C; Kratzig, ND; Pecoraro, M; Lange, S; Seifert, P; von Frankenberg, C; Untch, J; Zuleger, G; Wilhelm, M; Zolg, DP; Dreyer, FS; Braunlein, E; Engleitner, T; Uhrig, S; Boxberg, M; Steiger, K; Slotta-Huspenina, J; Ochsenreither, S; von Bubnoff, N; Bauer, S; Boerries, M; Jost, PJ; Schenck, K; Dresing, I; Bassermann, F; Friess, H; Reim, D; Grutzmann, K; Pfutze, K; Klink, B; Schrock, E; Haller, B; Kuster, B; Mann, M; Weichert, W; Frohling, S; Rad, R; Hiltensperger, M; Krackhardt, AM
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
NAT COMMUN. 2023; 14(1): 4632
Doi: 10.1038/s41467-023-39570-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Untergasser, A; Hellemans, J; Pfaffl, MW; Ruijter, JM; van, den, Hoff, MJB; Dragomir, MP; Adamoski, D; Dias, SMG; Reis, RM; Ferracin, M; Dias-Neto, E; Marsh, I; Kubista, M; Fabbri, M; Goel, A; Slabý, O; Knutsen, E; Chen, B; Negrini, M; Mimori, K; Pichler, M; Papatriantafyllou, M; Anfossi, S; Schmittgen, TD; Huggett, J; Bustin, S; Vandesompele, J; Calin, GA, , HEROIC, (tHe, initiativE, gRoup, On, qRT, dIsClosure), Consortium, , HEROIC, (tHe, initiativE, gRoup, On, qRT, dIsClosure), Consortium
Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action.
Mol Oncol. 2023;
Doi: 10.1002/1878-0261.13418
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vigier, M; Thorson, KR; Andritsch, E; Schwerdtfeger, AR
An Investigation of Patients' and Doctors' Autonomic Nervous System Responses Throughout News-Focused Medical Consultations.
Health Commun. 2023; 1-11
Doi: 10.1080/10410236.2023.2261714
Web of Science
PubMed
FullText
FullText_MUG
** Vitale, I; Pietrocola, F; Guilbaud, E; Aaronson, SA; Abrams, JM; Adam, D; Agostini, M; Agostinis, P; Alnemri, ES; Altucci, L; Amelio, I; Andrews, DW; Aqeilan, RI; Arama, E; Baehrecke, EH; Balachandran, S; Bano, D; Barlev, NA; Bartek, J; Bazan, NG; Becker, C; Bernassola, F; Bertrand, MJM; Bianchi, ME; Blagosklonny, MV; Blander, JM; Blandino, G; Blomgren, K; Borner, C; Bortner, CD; Bove, P; Boya, P; Brenner, C; Broz, P; Brunner, T; Damgaard, RB; Calin, GA; Campanella, M; Candi, E; Carbone, M; Carmona-Gutierrez, D; Cecconi, F; Chan, FK; Chen, GQ; Chen, Q; Chen, YH; Cheng, EH; Chipuk, JE; Cidlowski, JA; Ciechanover, A; Ciliberto, G; Conrad, M; Cubillos-Ruiz, JR; Czabotar, PE; D'Angiolella, V; Daugaard, M; Dawson, TM; Dawson, VL; De, Maria, R; De, Strooper, B; Debatin, KM; Deberardinis, RJ; Degterev, A; Del, Sal, G; Deshmukh, M; Di, Virgilio, F; Diederich, M; Dixon, SJ; Dynlacht, BD; El-Deiry, WS; Elrod, JW; Engeland, K; Fimia, GM; Galassi, C; Ganini, C; Garcia-Saez, AJ; Garg, AD; Garrido, C; Gavathiotis, E; Gerlic, M; Ghosh, S; Green, DR; Greene, LA; Gronemeyer, H; Häcker, G; Hajnóczky, G; Hardwick, JM; Haupt, Y; He, S; Heery, DM; Hengartner, MO; Hetz, C; Hildeman, DA; Ichijo, H; Inoue, S; Jäättelä, M; Janic, A; Joseph, B; Jost, PJ; Kanneganti, TD; Karin, M; Kashkar, H; Kaufmann, T; Kelly, GL; Kepp, O; Kimchi, A; Kitsis, RN; Klionsky, DJ; Kluck, R; Krysko, DV; Kulms, D; Kumar, S; Lavandero, S; Lavrik, IN; Lemasters, JJ; Liccardi, G; Linkermann, A; Lipton, SA; Lockshin, RA; López-Otín, C; Luedde, T; MacFarlane, M; Madeo, F; Malorni, W; Manic, G; Mantovani, R; Marchi, S; Marine, JC; Martin, SJ; Martinou, JC; Mastroberardino, PG; Medema, JP; Mehlen, P; Meier, P; Melino, G; Melino, S; Miao, EA; Moll, UM; Muñoz-Pinedo, C; Murphy, DJ; Niklison-Chirou, MV; Novelli, F; Núñez, G; Oberst, A; Ofengeim, D; Opferman, JT; Oren, M; Pagano, M; Panaretakis, T; Pasparakis, M; Penninger, JM; Pentimalli, F; Pereira, DM; Pervaiz, S; Peter, ME; Pinton, P; Porta, G; Prehn, JHM; Puthalakath, H; Rabinovich, GA; Rajalingam, K; Ravichandran, KS; Rehm, M; Ricci, JE; Rizzuto, R; Robinson, N; Rodrigues, CMP; Rotblat, B; Rothlin, CV; Rubinsztein, DC; Rudel, T; Rufini, A; Ryan, KM; Sarosiek, KA; Sawa, A; Sayan, E; Schroder, K; Scorrano, L; Sesti, F; Shao, F; Shi, Y; Sica, GS; Silke, J; Simon, HU; Sistigu, A; Stephanou, A; Stockwell, BR; Strapazzon, F; Strasser, A; Sun, L; Sun, E; Sun, Q; Szabadkai, G; Tait, SWG; Tang, D; Tavernarakis, N; Troy, CM; Turk, B; Urbano, N; Vandenabeele, P; Vanden, Berghe, T; Vander, Heiden, MG; Vanderluit, JL; Verkhratsky, A; Villunger, A; von, Karstedt, S; Voss, AK; Vousden, KH; Vucic, D; Vuri, D; Wagner, EF; Walczak, H; Wallach, D; Wang, R; Wang, Y; Weber, A; Wood, W; Yamazaki, T; Yang, HT; Zakeri, Z; Zawacka-Pankau, JE; Zhang, L; Zhang, H; Zhivotovsky, B; Zhou, W; Piacentini, M; Kroemer, G; Galluzzi, L
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Cell Death Differ. 2023; 30(5):1097-1154
Doi: 10.1038/s41418-023-01153-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wimmer, K; Sachet, M; Ramos, C; Frantal, S; Birnleitner, H; Brostjan, C; Exner, R; Filipits, M; Bago-Horvath, Z; Rudas, M; Bartsch, R; Gnant, M; Singer, CF; Balic, M; Egle, D; Oehler, R; Fitzal, F
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.
J Exp Clin Cancer Res. 2023; 42(1):300
Doi: 10.1186/s13046-023-02876-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wöll, E; Amann, A; Eisterer, W; Gerger, A; Grünberger, B; Rumpold, H; Weiss, L; Winder, T; Greil, R; Prager, GW
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
Anticancer Res. 2023; 43(7):2889-2897
Doi: 10.21873/anticanres.16460
Web of Science
PubMed
FullText
FullText_MUG
Terbuch, T
Thromboembolieprophylaxe - wie, für wen und wie lange?
Jatros Haematologie und Onkologie. 2023; (8/2023): 24-25.
Conference papers, proceedings, abstracts
** Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2917
[Poster]
Web of Science
FullText
FullText_MUG
** Bartsch, R; Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Wuerstlein, R; Zahn, MO; Luftner, D; Schwitter, M; Balic, M; Jackisch, C; Muller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinkothe, T; Gorray, M; Breitenstein, U
Interim analysis of ELEANOR (n=200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
BREAST. 2023; 68: S20-S21.
[Poster]
Web of Science
** Bartsch, R; Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Würstlein, R; Zahn, MO; Lüftner, D; Schwitter, M; Balic, M; Jackisch, C; Müller, ; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinköthe, T; Vannier, C; Breitenstein, U
Interim analysis (n=200) of ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib in the clinical routine
ONCOL RES TREAT. 2023; 46: 170-171.
[Poster]
Web of Science
** Champiat, S; Boyer, MJ; Govindan, R; Paz-Ares, LG; Owonikoko, TK; Borghaei, H; Izumi, H; Steeghs, N; Blackhall, FH; Terbuch, A; Johnson, ML; Yoshida, T; He, K; Zhang, YY; Jones, S; Chen, X; Martinez, P; Hummel, HD
Tarlatamab in small cell lung cancer (SCLC): Safety and efficacy analyzed by baseline brain metastasis
J CLIN ONCOL. 2023; 41(16):
[Poster]
Web of Science
** Dandachi, N; Graf, R; Pancheri, L; Dobric, N; Klocker, EV; Suppan, C; Jost, PJ; Heitzer, E; Balic, M
A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
ANN ONCOL. 2023; 34: S1162-S1163.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN.
Doi: 10.1016/j.annonc.2023.09.1289
[Poster]
Web of Science
FullText
FullText_MUG
** Dill, V; Kirmes, K; Klug, M; Herhaus, P; Ruland, J; Bassermann, F; Götze, KS; Jilg, S; Jost, PJ; Bongiovanni, D
Detection of dysregulated prothrombotic pathways by platelet mass cytometry in patients with essential thrombocythemia
ONCOL RES TREAT. 2023; 46: 222-222.
[Poster]
Web of Science
** Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M
Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
ANN ONCOL. 2023; 34: S387-S387.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN.
Doi: 10.1016/j.annonc.2023.09.667
[Poster]
Web of Science
FullText
FullText_MUG
** Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Dandachi, N; Vosberg, S; Greif, PA;
FREQUENT TRUNCATING MUTATIONS IN TET2 GENE AND A DISTINCT DNA METHYLATION SIGNATURE CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH ISOLATED TRISOMY 4
ANN HEMATOL. 2023; 102(SUPPL 1):S26-S27.-ACUTE LEUKEMIAS XVIII .ISALXVIII
BIOLOGY AND TREATMENT STRATEGIES; March 19-20, 2023; Munich Germany.
[Poster]
Web of Science
** George, M; Brandl, WT; Richtig, E; Richtig, G; Wadsack, C; Hirschmugl, B
INTERPLAY BETWEEN PREGNANCY ASSOCIATED MELANOMA CELLS AND PLACENTAL TISSUE
PLACENTA. 2023; 140: E76-E76.-Annual Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 05-08, 2023; Rotorua, NEW ZEALAND.
[Poster]
Web of Science
** He, K; Absenger, G; Pickering, C; Guerrier, C; Dhar, C; Xu, G; Hartness, J; Rice, R; Schwarz, F; Serie, D; Hommes, D; Brcic, L
Decoding the glycan code: Pioneering early detection of non-small cell lung cancer through glycoproteomics
ANN ONCOL. 2023; 34: S724-S724.
Doi: 10.1016/j.annonc.2023.09.2330
[Poster]
Web of Science
FullText
FullText_MUG
** Hilbers, F; Venet, D; Agostinetto, E; Benelli, M; Guerrero, A; Martins-Branco, D; Raimbault, A; Fimereli, D; Ferrando, L; Sommariva, S; Biagioni, C; Paoli, M; Llinas-Bertran, A; Dadiani, M; Zoppoli, G; Balic, M; Albanell, J; Vosberg, S; Irrthum, A; Salgado, R
Characterization of the immune microenvironment in matched primary and metastatic breast cancer lesions from the AURORA study: BIG 14-01
J CLIN ONCOL. 2023; 41(16):
[Poster]
Web of Science
** Hofer, S; Andreou, D; Gelderblom, H; Haas, R; Kunz, W; Leithner, A; Szkandera, J; Reichardt, P; Judson, I; Jones, R; Lindner, L; Desar, I; Liegl-Atzwanger, B; van der Graaf, W; Jakob, J; Miah, A; Rutkowski, P; Wardelmann, E; Rothermundt, C
Controversies in the management of patients with soft tissue sarcoma: the top recommendations of the Conference on State of Science in Sarcoma (CSSS)
ONCOL RES TREAT. 2023; 46: 156-156.
Web of Science
** Koeberle, D; Kisro, J; Muller-Huesmann, H; Wierecky, J; von der Heyde, E; Stübs, P; Bürkle, D; Schmidt, B; Forstbauer, H; Nora, H; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Prager, G; Stintzing, S
Disease characteristics and real-world treatment pathways of BRAF V600E-mutant metastatic colorectal cancer patients: Analysis of 120 patients enrolled in the BERING CRC study
ONCOL RES TREAT. 2023; 46: 158-158.
[Poster]
Web of Science
** Koschmieder, S; Isfort, S; Teichmann, LL; Schafhausen, P; Heidel, F; Hochhaus, A; Griesshammer, M; Sockel, K; Jost, P; Wolleschak, D; Döhner, K; Goethert, JR; Radsak, MP; Augustin, M; Becker, H; Giagounidis, A; Schaich, M; Klausmann, M; Von Bubnoff, N; Stegelmann, F; Kortmann, M; Frank, J; Hellmich, M; Brümmendorf, TH
Firstline Treatment with Ruxolitinib Versus Best Available Therapy in Patients with Polycythemia Vera: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
BLOOD. 2023; 142:
Doi: 10.1182/blood-2023-173225
Web of Science
FullText
FullText_MUG
** Lorch, M; Pfirrmann, M; Fabisch, C; Oberle, L; Kohn, D; Kohlbrenner, K; Brümmendorf, TH; Burchert, A; Krause, SW; le Coutre, P; Hänel, M; Franke, GN; Stegelmann, F; Radsak, MP; Kunzmann, ; Jost, PJ; Baerlocher, GM; Mayer, J; Hofmann, WK; Hochhaus, A; Saussele, S
Health-related quality of life (HRQoL) effects of pegylated Interferon α2b (PEG-IFN) in Nilotinib (NIL)-based treatment of chronic myeloid leukemia (CML)
ONCOL RES TREAT. 2023; 46: 279-280.
[Poster]
Web of Science
** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
** Lyssy, F; Lind, K; Zöscher, F; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H; Dutta, S
Modelling drug resistance conferred by mono- and bi-allelic TP53 aberrations using isogenic AML cell lines
ONCOL RES TREAT. 2023; 46: 188-189.
[Poster]
Web of Science
FullText
** Massari, F; Pulido, EG; Bamias, A; Iacovelli, R; Cerrillo, JM; Procopio, G; Fiala, O; Myint, ZW; De Giorgi, UFF; Buchler, T; Santini, D; Büttner, T; Roviello, G; Pichler, M; de los Rios, MTB; Rizzo, A; Monteiro, FSM; Buti, S; Porta, CG; Santoni, M
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immunecombinations
ANN ONCOL. 2023; 34: S1021-S1021.
Doi: 10.1016/j.annonc.2023.09.1127
[Poster]
Web of Science
FullText
FullText_MUG
** Neufeldt, D; Jonas, K; Rinner, B; Szkandera, J; Rank, A; Jahn, S; Liegl-Atzwanger, B; Trepel, M; Pichler, M
Long non-coding RNA PANTR1 is associated with poor prognosis in sarcoma
ONCOL RES TREAT. Abstracts. 2023; 46(S5):156-156.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 13-16, 2023; Hamburg, GERMANY.
[Oral Communication]
Web of Science
** Niedersüss-Beke, D; Krauter, J; Shariat, S; Pichler, R; Barth, D; Pichler, M; Weibrecht, S; Marszalek, M; Stoiber, F; Mayerhofer, K
Real-world data registry on patients treated with enfortumab vedotin in metastaic urothelial cancer in Austria
ONCOL RES TREAT. Abstracts. 2023; 46(S5):323-323.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 13-16, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
** Paffenholz, P; Landwehr, G; Seidel, C; Poch, A; Bokemeyer, C; Cathomas, R; Pongratanakul, P; Hiester, A; Albers, P; Pichler, M; Krege, S; Syring-Schmandke, ; Heinzelbecker, J; Nestler, T; Pfister, D; Heidenreich, A
Non-seminomatous testicular germ cell tumours with teratoma-free primaries exhibit a superior early relapse-free survival
EUR UROL. 2023; 83:
[Poster]
Web of Science
** Paffenholz, P; Landwehr, G; Seidel, CA; Poch, A; Bokemeyer, C; Cathomas, R; Pongratanakul, P; Hiester, A; Albers, P; Pichler, M; Krege, S; Syring, I; Heinzelbecker, J; Nestler, T; Pfister, D; Heidenreich, A
Relapse-free and overall survival in patients with non-seminomatous testicular germ cell tumours with teratoma-free primaries.
J CLIN ONCOL. 2023; 41:
[Poster]
Web of Science
** Prager, G; Kisro, J; Muller-Huesmann, H; von der Heyde, E; Stubs, P; Burkle, D; Schmidt, B; Forstbauer, H; Hagemeyer, N; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, A; Winder, T; Koeberle, D; Stintzing, S
Disease characteristics and real-world treatment pathways of BRAF V600E-mutant metastatic colorectal cancer patients: Analysis of 120 patients enrolled in the BERING CRC study
ANN ONCOL. 2023; 34: S11-S11.
Doi: 10.1016/j.annonc.2023.04.052
[Poster]
Web of Science
FullText
FullText_MUG
** Riedl, JM; Steinlechner, SM; Moik, F; Heitzer, E; Jahn, S; Hasenleithner, S; Doleschal, B; Weiss, L; Seeber, A; Rumpold, H; Winder, T; Greil, R; Jost, PJ; Hoefler, G; Speicher, M; Gerger, A
SOUND: A phase II trial evaluating the efficacy of molecular profiling of circulating ± tumor tissue DNA for salvagetherapy matching in patients with advanced and refractory carcinoma
ANN ONCOL. 2023; 34: S1186-S1186.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.1349
[Poster]
Web of Science
FullText
FullText_MUG
** Shahbaz, W; Jurinovic, V; Batcha, AMN; Rausch, C; Rothenberg-Thurley, M; Dufour, AM; Ksienzyk, B; Schneider, S; Neusser, M; Sauerland, MC; Görlich, D; Berdel, WE; Woermann, BJ; Krug, U; Braess, J; Hiddemann, W; Mansmann, U; Vosberg, S; Greif, PA; Spiekermann, K; Metzeler, KH; Herold, T
D DX41-Low Expression Mimics Germline DDX41-Phenotype in Acute Myeloid Leukemia
BLOOD. 2023; 142:
Doi: 10.1182/blood-2023-187419
Web of Science
FullText
FullText_MUG
** Singer, CF; Konig, F; Kacerovsky-Strobl, S; Danzinger, S; Brunner, C; Suppan, C; Deutschmann, C; Balic, M; Greil, R; Egle, D; De Azambuja, E; Di Cosimo, S; Gnant, M
Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial
J CLIN ONCOL. 2023; 41(16):
[Poster]
Web of Science
** Stintzing, S; Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, RD; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Ohler, L; Gruenberger, B; Niedersuess-Beke, D; Winder, T; Trojan, J; Prager, GW; Baraniskin, A; Klein-Scory, S
Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC.
J CLIN ONCOL. 2023; 41(16):
[Poster]
Web of Science
** Stintzing, S; von der Heyde, E; Wierecky, J; Bürkle, D; Forstbauer, H; Hübner, G; Schmidt, B; Schroeder, J; Distelrath, A; Flum, M; Reichenbach, F; Arnold, D; Fritsch, RM; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Prager, GW
Disease characteristics and clinical practice of BRAF V600E-mutant metastatic colorectal cancer treatment: Baseline analysis of patients enrolled in the BERING CRC study.
J CLIN ONCOL. 2023; 41: 34-34.
[Poster]
Web of Science
** Stintzing, S; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, RD; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Öhler, L; Gruenberger, B; Niedersuess-Beke, D; Sandmann, M; Winder, T; Trojan, J; Prager, G; Heinemann, V
Phase III FIRE-4 study (AIO KRK-0114): Evaluation of first-line treatment efficacy of FOLFIRI/cetuximab in patients with RAS-WT mCRC receiving the first cycle of treatment with chemotherapy only.
J CLIN ONCOL. 2023; 41: 100-100.
[Poster]
Web of Science
** Vosberg, S; Ohnmacht, A; Moser, C; Arneth, A; Jurinovic, V; Metzeler, KH; Amler, S; Sauerland, MC; Görlich, D; Berdel, WE; Braess, J; Hiddemann, W; Spiekermann, K; Oakes, CC; Menden, MP; Herold, T; Greif, PA
REFINING THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA BASED ON DNA METHYLATION PROFILING
ANN HEMATOL. 2023; 102(SUPPL 1): S42-S43.
[Poster]
Web of Science
** Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Strobl-Kacerovsky, S; Greil, R; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Solkner, L; Fesl, C; Gnant, M; Fitzal, F
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
BREAST. 2023; 68: S123-S124.
[Poster]
Web of Science
** Zurl, H; Embacher, S; Schollnast, H; Talakic, E; Geyer, M; Schopfer-Schwab, S; Rosenlechner, D; Scheipner, L; Jasarevic, S; Seidl, M; Altziebler, J; Mannweiler, S; Riedl, J; Schwantzer, G; Ahyai, S; Mischinger, J
Prostate tumor volume is a significant predictor to identify patients with no need for concomitant systematic biopsy in men undergoing transrectal ultrasound- MRI fusion guided biopsy of the prostate
EUR UROL. Abstracts. 2023; 83(S1):S442-S442.-38th Annual EAU Congress; MAR 10-13, 2023; Milan, ITALY.
[Poster]
Web of Science
Andreou, D; Rothermund, C; Gelderblom, H; Haas, R; Kunz, WG; Leithner, A; Lindner, LH; Liegl-Atzwanger, B; Szkandera, J; Hofer, S
Controversies in the management of patients with soft tissue sarcoma: the top recommendations of the Conference on State of Science in Sarcoma (CSSS) 2022.
Abstract book of the 35th Annual Meetin European Musculo-Sceletal Oncology Society. 2023; 51--EMSOS 2023; May 10-12, 2023; Brüssel, BELGIEN.
[Oral Communication]
Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA.
[Oral Communication]
FullText
Buono, G; Deleuze A; Klocker, EV; Nardin, S; Eiriz IF; Luz, PJC; Braga, S; Harbeck, N; Dieras, VC
237P - Real-world safety and efficacy of Trastuzumab-Deruxtecan (T-DXd) in HER2-positive advanced breast cancer (ABC) elderly patients (pts): the TREX-Old retrospective registry
Session Poster viewing and lunch. 2023; Annals of Oncology(8):101223-101223.-ESMO Breast Cancer Congress; MAY 11-13, 2023; Berlin, Germany.
C Englisch , F Moik , J Thaler , S Koder , M Preusser , I Pabinger , C Ay
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research. 2023; 43(S01):S23--67th Annual Meeting of the Society of Thrombosis and Haemostasis Research; Feb 21-24, 2023; Frankfurt, Germany.
[Oral Communication]
FullText
Dandachi, N; Graf, R; Pancheri, L; Dobric, N; Klocker, EV; Suppan, C; Jost, PJ; Heitzer, E; Balic, M
Sensitive detection of circulating tumor DNA using targeted capture sequencing in advanced HR+/HER2- breast cancer patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE.
[Poster]
FullText
Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M.
Comparison of ctDNA fraction and mutational profiles of plasma samples of HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE.
[Poster]
FullText
Englisch, C; Moik, F; Thaler, J; Koder, S; Preusser, M; Pabinger, I; Ay, C
Tissue Factor Pathway Inhibitor is Associated with Risk of Venous Thromboembolism and All-Cause Mortality in Patients with Cancer
Abstracts from the ISTH 2023 Congress. 2023; 7(S2):232-233.-ISTH 2023 Congress; JUN 24–28, 2023; Montreal, Canada.
[Oral Communication]
FullText
F Moik , S Kraler , F Montecucco , L Liberale , S Nopp , C Englisch , T Lapikova-Bryhinska , A Akhmedov , A von Eckardstein , F Wenzl , I Pabinger , T Lüscher , C Ay
Cardiovascular biomarkers for the prediction of adverse cardiovascular events and mortality in patients with cancer
GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research. 2023; 44(S01):S23-S24.-67th Annual Meeting of the Society of Thrombosis and Haemostasis Research; Feb 21-24, 2023; Frankfurt, Germany.
[Oral Communication]
FullText
Huemer, M; Hofmann G; Gurban J; Sciri E; Portugaller S; Bitsche S; Jahn-Kuch D
Symptom Clusters of Cancer-related Fatigue in Patients with Cancer Cachexia.
EAPC2023 Abstract Book. 2023; 37(1S):84-84.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Huemer, M; Odler, B; Schweiger, E; Borenich, A; Kurnikowski, A; Krall, M; Hafner-Giessauf, H; Pascual, J; Budde, K; Rosenkranz, AR; Hecking, M; Eller, K
The Burden of Kidney Disease Influences the Health-related Quality of Life in Kidney Transplant Recipients over Time.
EAPC2023 Abstract Book.. 2023; 37(S1):229-230.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch D; Pichler, M
Gender Differences in Using Complementary and Alternative Medicine in Cancer Patients: A Cross-sectional Study.
EAPC2023 Abstract Book. 2023; 37(1S):92-92.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Huemer, M; Pichler, M; Richtig, G
Is Palliative Care Research Biased towards Oncology? Trends in Literature from 2000 to 2021: A Bibliometric Big Data Analysis.
EAPC2023 Abstract Book.. 2023; 37(S1):198-198.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Leithner, A; Seidel, MG; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E; Kashofer, K
Introducting liquid biopsy for paediatric patients into the clinical routine
Proceedings of the ESMO Sarcoma and Rare Cancers Congress 2023. 2023; -ESMO Sarcoma and Rare Cancers Congress; MAR 20-22, 2023; Lugano, SWITZERLAND.
[Poster]
Moazzami, AA; Zügner, E; Prietl, B; Stradner, M; Stanzer, S; Franz, J; Mattersdorfer, K; Schimek, D; Prugger, EM; Magnes, C; Sourij, H; Pieber,TR
Metabolomics analysis reveals common and differentiating metabolic phenotypes in PBMCs from T1D, SLE and healthy participants
Proceedings of the 23rd FOCIS. 2023; -23rd Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS); June 20-23, 2023; Boston, USA.
[Poster]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E
Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA.
[Poster]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E.
It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY.
[Poster]
Nopp, S; Moik, F; Kraler, S; Englisch, C; Preusser, M; von Eckardstein, A; Pabinger, I; Lüscher, T; Ay C
Association of Growth Differentiation Factor-15 (GDF-15) with Thromboembolism and Mortality in Patients with Cancer: Findings from the Vienna CATS Study
Abstracts from the ISTH 2023 Congress. 2023; 7(S2):231-232.-ISTH 2023 Congress; JUN 24–28, 2023; Montreal, Canada.
[Oral Communication]
FullText
Remschmidt, B; Rieder, M; Gässler, J; Muallah, D; Wallner, J; Brcic, L
The impact of COVID-19 on oral squamous cell carcinoma's diagnostic stage—A retrospective study
Oral Diseases. 2023; -OEGMKG 2023; JAN 31-FEB 3, 2023; Bad Hofgastein.
[Oral Communication]
FullText
Rieder, M; Wallner, J; Schwaiger, M; Remschmidt, B; Zemann, W; Pau, M
Donor Site Morbidity and Quality of Life after Microvascular Head and Neck Reconstruction with a Chimeric, Thoracodorsal, Perforator-Scapular Flap Based on the Angular Artery (TDAP-Scap-aa Flap)
Journal of Clinical Medicine. 2023; -OEGMKG 2023; JAN 31 - FEB 2,2023; Bad Hofgastein, AUSTRIA.
[Poster]
FullText
Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thüringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Liquid Biopsy In Paediatric Ewing Sarcoma Patients: A Pilot Study.
Abstracts of the 24th EFORT Annual Congress:#2198. 2023; -24th EFORT Annual Congress; MAY 24-26, 2023; Vienna, AUSTRIA.
[Oral Communication]
Smolle, MA; Herbsthofer, L; Prietl, B; El-Heliebi, A; Pichler, M; Tomberger, M; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J
Impact Of Tumour-Infiltrating Immune Cells On Oncological Outcome (Local Recurrence, Distant Metastasis, Overall Survival) In Soft Tissue Sarcoma Patients.
Online Abstract Book of the 24th EFORT Congress. 2023; -24th EFORT Congress; MAY 24-26, 2023; Vienna, AUSTRIA.
[Oral Communication]
Smolle, MA; Musser, E; Bergovec, M; Wibmer, CL; Leitner, L; Scheipl, S; Sorensen, MS; Friesenbichler, J; Petersen, MM; Brcic, I; Szkandera, J; Leithner, A
Validation Of The 2013-SPRING Model For Survival Prediction In Surgically Treated Patients With Long-Bone Metastases Using An External Cohort.
Online Abstract Book of the 24th EFORT Congress. 2023; -24th EFORT Congress; MAY 24-26, 2023; Vienna, AUSTRIA.
[Oral Communication]
Valentini, M; Szkandera, J; Scheipl, S; Smolle, MA; Leithner, A; Andreou, D
Artificial Intelligence Bot ChatGPT: is it a trustworthy and reliable source of information for patients?.
Abstract Book of the 35th Annual Meeting European Musculo-Skeletal Oncology Society. 2023; 40--EMSOS 2023; MAY 10-12, 2023; Brüssel, BELGIEN.
[Oral Communication]
Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E
Investigating Homologous Recombination Deficiency in mCRPC through ctDNA.
ISMRC 13th International Symposium on Minimal Residual Cancer Book of Abstracts. 2023; -ISMRC 13th International Symposium on Minimal Residual Cancer; MAY 2-4, 2023;; Hamburg, GERMANY.
[Poster]
Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E
ctDNA can infer Homologous Recombination Deficiency in mCRPC patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE.
[Poster]
Zurl, H; Embacher, S; Schöllnast, H; Talakic, E; Geyer, M; Schöpfer-Schwab, S; Rosenlechner, D; Scheipner, L; Jasarevic, S; Seidl, M; Altziebler, J; Simunovic, I; Bele, U; Mannweiler, S; Riedl, J; Ahyai, S; Mischinger, J
Das Prostatatumorvolumen ist ein signifikanter Prädiktor, um eine konkomitante systematische Biopsie nach transrektaler Ultraschall-MRT-Fusionsbiopsie der Prostata vermeiden zu können
DOI: 10.3205/23oegu64. 2023; -49. Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; Österreichische Gesellschaft für Urologie und Andrologie; Bayerische Urologenvereinigung; Linz, Österreich; MAI 4-6, 2023; Linz, AUSTRIA.
[Oral Communication]
FullText
Miscellaneous publications
Richtig, E; Jost, Ph; Sendlhofer, G; Urban-Haas, M.
Qualitätssicherungsmaßnahmen zur Steigerung der Therapie-Adhärenz in der klinischen Praxis
. 2023
Presentation science to public
Huemer, M
Schmerz und seine Therapie
Community Nurses Feldbach; JUL 4, 2023; Feldbach, AUSTRIA. 2023.
[Science to Public]
Huemer, M
Palliativmedizin - mehr als nur Sterbemedizin.
Community Nurses Feldbach; OCT 3, 2023; Feldbach, AUSTRIA. 2023.
[Science to Public]